<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN)</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN)</h1>
  <ul>
<li>(NASDAQ:REGN) with a price target of $640.</li>
<li>READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.</li>
<li>On September 8, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron Pharmaceuticals, Inc.</li>
<li>Disclosure: None.</li>
<li>Regeneron Pharmaceuticals, Inc.</li>
<li>This article is originally published at Insider Monkey.</li>
<li>Seigerman notes the clinical data address a large unmet medical need.</li>
</ul>
<p><a href="https://finance.yahoo.com/news/bmo-capital-maintains-buy-regeneron-121529852.html">Source</a> · 2025-09-15T12:15:29+00:00</p>
</body>
</html>